INSP
Inspire Medical Systems Inc

1,563
Loading...
Loading...
News
all
press releases
Why Is Inspire (INSP) Up 7.5% Since Last Earnings Report?
Inspire (INSP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·16d ago
News Placeholder
More News
News Placeholder
Is the Options Market Predicting a Spike in Inspire Medical Systems Stock?
Investors need to pay close attention to INSP stock based on the movements in the options market lately.
Zacks·28d ago
News Placeholder
Nyxoah Secures FDA Clearance for Genio System to Treat Sleep Apnea
NYXH wins FDA approval for its leadless, battery-free Genio sleep apnea therapy, backed by strong trial results.
Zacks·1mo ago
News Placeholder
Inspire Medical Systems Stock Slumps On Downgrades, Price Target Cuts: Retail Believes Stock Is Way Oversold
Truist said it was braced for a guidance cut, but it was bigger than expected, and a lower earnings per share outlook reduces the stock valuation floor.
Stocktwits·2mo ago
News Placeholder
INSP Stock Plunges Despite Q2 Earnings Beat, Gross Margin Contracts
Inspire Medical tops second-quarter 2025 earnings estimates and posts solid revenue growth, but trims 2025 guidance amid margin pressure.
Zacks·2mo ago
News Placeholder
Compared to Estimates, Inspire (INSP) Q2 Earnings: A Look at Key Metrics
The headline numbers for Inspire (INSP) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks·2mo ago
News Placeholder
Inspire Medical Systems (INSP) Q2 Earnings and Revenues Surpass Estimates
Inspire (INSP) delivered earnings and revenue surprises of +104.55% and +0.95%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Butterfly Network, Inc. (BFLY) Reports Q2 Loss, Misses Revenue Estimates
Butterfly Network (BFLY) delivered earnings and revenue surprises of +14.29% and -2.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Doximity (DOCS) Reports Next Week: Wall Street Expects Earnings Growth
Doximity (DOCS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·2mo ago
News Placeholder
Can Sustained Product Demand Drive HIMS Stock Before Q2 Earnings?
Hims & Hers benefits from strong product demand and subscriber growth ahead of second-quarter 2025 earnings, fueled by weight loss and specialty care uptake.
Zacks·2mo ago

Latest INSP News

View

Advertisement. Remove ads.

Advertisement. Remove ads.